Baillie Gifford & Co’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122M | Sell |
|
|||||
|
2025
Q1 | $129M | Sell |
|
|||||
|
2024
Q4 | $168M | Sell |
|
|||||
|
2024
Q3 | $166M | Sell |
|
|||||
|
2024
Q2 | $199M | Buy |
|
|||||
|
2024
Q1 | $240M | Sell |
|
|||||
|
2023
Q4 | $238M | Sell |
|
|||||
|
2023
Q3 | $188M | Sell |
|
|||||
|
2023
Q2 | $187M | Sell |
|
|||||
|
2023
Q1 | $168M | Buy |
|
|||||
|
2022
Q4 | $191M | Buy |
|
|||||
|
2022
Q3 | $230M | Sell |
|
|||||
|
2022
Q2 | $176M | Sell |
|
|||||
|
2022
Q1 | $157M | Sell |
|
|||||
|
2021
Q4 | $379M | Buy |
|
|||||
|
2021
Q3 | $508M | Buy |
|
|||||
|
2021
Q2 | $676M | Buy |
|